These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29729048)

  • 21. [Hypoglycaemia in patients with type 1 and type 2 diabetes mellitus on insulin therapy. Results of the global HAT study in Argentina].
    Costa Gil JE; Linari MA; Pugnaloni N; Zambon FG; Pérez Manghi F; Rezzónico M;
    Medicina (B Aires); 2017; 77(6):449-457. PubMed ID: 29223934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoglycaemia assessment tool (HAT) study: subanalysis of the Lebanese cohort.
    Amm M; Rawas M; Francis Z; Chehabeddine M; Chalfoun A; El Akel M; Merheb M
    East Mediterr Health J; 2020 Aug; 26(8):939-947. PubMed ID: 32896889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
    Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
    Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12-month prospective observational study.
    Dunkley AJ; Fitzpatrick C; Gray LJ; Waheed G; Heller SR; Frier BM; Davies MJ; Khunti K;
    Diabetes Obes Metab; 2019 Jul; 21(7):1585-1595. PubMed ID: 30843327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.
    Garber AJ; King AB; Del Prato S; Sreenan S; Balci MK; Muñoz-Torres M; Rosenstock J; Endahl LA; Francisco AM; Hollander P;
    Lancet; 2012 Apr; 379(9825):1498-507. PubMed ID: 22521072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study.
    Abusnana S; Beshyah SA; Al-Mutawa N; Tahhan R; Jallo M; Arora R; Aly H; Singhal S
    Sultan Qaboos Univ Med J; 2018 Nov; 18(4):e447-e454. PubMed ID: 30988962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study.
    de Valk HW; Feher M; Hansen TK; Jendle J; Koefoed MM; Rizi EP; Zimmermann E; Fadini GP
    Diabetes Ther; 2020 Sep; 11(9):2159-2167. PubMed ID: 32666165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents.
    Jabbar A; Hassanein M; Beshyah SA; Boye KS; Yu M; Babineaux SM
    Diabetes Res Clin Pract; 2017 Oct; 132():19-26. PubMed ID: 28783529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study.
    Heller SR; Geybels MS; Iqbal A; Liu L; Wagner L; Chow E
    Diabetologia; 2022 Jan; 65(1):55-64. PubMed ID: 34704120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe (level 3) hypoglycaemia occurrence in a real-world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States).
    Ratzki-Leewing A; Black JE; Kahkoska AR; Ryan BL; Zou G; Klar N; Timcevska K; Harris SB
    Diabetes Obes Metab; 2023 Dec; 25(12):3736-3747. PubMed ID: 37700692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
    Pieber TR; Arfelt KN; Cailleteau R; Hart M; Kar S; Mursic I; Svehlikova E; Urschitz M; Haahr H
    Diabetologia; 2023 Aug; 66(8):1413-1430. PubMed ID: 37308751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized.
    Nirantharakumar K; Marshall T; Kennedy A; Narendran P; Hemming K; Coleman JJ
    Diabet Med; 2012 Dec; 29(12):e445-8. PubMed ID: 22937877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
    Bolli GB; Riddle MC; Bergenstal RM; Ziemen M; Sestakauskas K; Goyeau H; Home PD;
    Diabetes Obes Metab; 2015 Apr; 17(4):386-94. PubMed ID: 25641260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study.
    Home P; Calvi-Gries F; Blonde L; Pilorget V; Berlingieri J; Freemantle N
    Diabetes Obes Metab; 2018 Apr; 20(4):921-929. PubMed ID: 29205734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
    Jones GC; Khan J; Sainsbury CAR
    Acta Diabetol; 2017 Mar; 54(3):247-250. PubMed ID: 27896444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T).
    Levy JC; Davies MJ; Holman RR;
    Diabetes Res Clin Pract; 2017 Sep; 131():161-168. PubMed ID: 28750219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects.
    Frier BM; Jensen MM; Chubb BD
    Diabet Med; 2016 Aug; 33(8):1125-32. PubMed ID: 26248501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.